ES2131574T3 - Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos. - Google Patents

Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos.

Info

Publication number
ES2131574T3
ES2131574T3 ES93901678T ES93901678T ES2131574T3 ES 2131574 T3 ES2131574 T3 ES 2131574T3 ES 93901678 T ES93901678 T ES 93901678T ES 93901678 T ES93901678 T ES 93901678T ES 2131574 T3 ES2131574 T3 ES 2131574T3
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
pct
alkoxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901678T
Other languages
English (en)
Inventor
Lawrence Stephen The Boo Clegg
Ian Michael The Boo Hunneyball
Colin Gerhart Pryce Jones
Paul The Boots Compan Rafferty
Leslie The Boots Compan Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Technology Group Inter Corporate Licensing Ltd
Original Assignee
British Technology Group Inter Corporate Licensing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Inter Corporate Licensing Ltd filed Critical British Technology Group Inter Corporate Licensing Ltd
Application granted granted Critical
Publication of ES2131574T3 publication Critical patent/ES2131574T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Abstract

ESTE INVENTO RELATA A COMPONENTES DE FORMULA (Y) Y LAS SALES DE ELLO ACEPTABLES FARMACEUTICAMENTE EN EL QUE R1, R2 Y R3 INDEPENDIENTEMENTE REPRESENTAN HIDROGENO, HALO, ALQUIL, ALCOXI, FENOXI, FENIL, ALCOXICARBONIL, -NR13R14, ALCOXIHALOGENADO, ALQUIL HALOGENADO, BENZILOXI, HIDROXI, HIDROXIALQUIL, (C26ALCOXICARBONIL)VINIL, -S(O)NR7, CARBAMOILALQUIL, ALCOXICARBONILALQUIL, -CONR11R12, O R1 Y R2 JUNTOS CON EL ANILLO FENIL REPRESENTAN UN GRUPO NAFTIL; R4 Y R5 INDEPENDIENTEMENTE REPRESENTAN HIDROGENO, ALQUIL, FENIL O JUNTOS CON EL ATOMO DE CARBONO REPRESENTAN C3-6 CICLOALQUIL; R6 REPRESENTA HIDROGENO, ALQUIL O WHIDROXI ALQUIL; A REPRESENTA C2-9 ALQUILENO; R8 REPRESENTA HIDROGENO, ALQUIL HALO, ALCOXI, HIDROXIALCOXI, BENZIL O FENIL; R9 Y R10 INDEPENDIENTEMENTE REPRESENTAN HIDROGENO, ALQUIL, HALO, ALCOXI, FENIL, HIDROXIALQUIL, ALCOXICARBONIL, NITRO, ILOXIALQUIL O AMINOMETIL; QUE SON AGENTES ANTIINFLAMATORIOS Y ANTIALERGICOS. TAMBIEN SON DESCUBIERTAS LAS COMPOSICIONES QUE CONTIENEN ESOS COMPONENTES YLOS PROCESOS PARA HACERLOS.
ES93901678T 1991-12-23 1992-12-12 Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos. Expired - Lifetime ES2131574T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919127304A GB9127304D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
CN93107988A CN1037511C (zh) 1991-12-23 1993-06-22 1－(芳烷基－氨烷基)咪唑化合物的制备方法

Publications (1)

Publication Number Publication Date
ES2131574T3 true ES2131574T3 (es) 1999-08-01

Family

ID=36822309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901678T Expired - Lifetime ES2131574T3 (es) 1991-12-23 1992-12-12 Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos.

Country Status (29)

Country Link
US (1) US5547972A (es)
EP (1) EP0618907B1 (es)
JP (1) JP2633087B2 (es)
CN (1) CN1037511C (es)
AT (1) ATE179416T1 (es)
AU (1) AU656839B2 (es)
BG (1) BG98812A (es)
CA (1) CA2126177A1 (es)
CZ (1) CZ153394A3 (es)
DE (1) DE69229057T2 (es)
ES (1) ES2131574T3 (es)
FI (1) FI943020A (es)
GB (1) GB9127304D0 (es)
HR (1) HRP921457A2 (es)
HU (2) HUT67372A (es)
IL (1) IL104168A (es)
IN (1) IN174436B (es)
MX (1) MX9207491A (es)
NO (1) NO304373B1 (es)
NZ (1) NZ246336A (es)
PH (1) PH30660A (es)
PL (1) PL172497B1 (es)
RO (1) RO113985B1 (es)
RU (1) RU2118957C1 (es)
SI (1) SI9200411A (es)
SK (1) SK75294A3 (es)
WO (1) WO1993013075A1 (es)
YU (1) YU48294B (es)
ZA (1) ZA929914B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741800A (en) * 1993-06-22 1998-04-21 Knoll Aktiengesellachaft Azolyl-cyclic amine derivates with immunomodulatory activity
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
WO1995022327A1 (en) * 1994-02-22 1995-08-24 Knoll Ag Use of 1-(arylalkylaminoalkyl) imidazoles for treating neurological damage
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
US6080870A (en) * 1996-04-03 2000-06-27 Merck & Co., Inc. Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6063930A (en) * 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
DE19850301A1 (de) 1998-10-30 2000-05-04 Basf Ag Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren
EP1741709A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
WO2016126957A1 (en) * 2015-02-04 2016-08-11 The Board Of Trustees Of The University Of Alabama Gas treating solutions containing imidazole-amine compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
DE2107487A1 (de) * 1970-02-26 1971-09-09 CIBA Geigy AG, Basel (Schweiz) Neue Amine und Verfahren zu ihrer Herstellung
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4404387A (en) * 1980-09-17 1983-09-13 The Upjohn Company Aminoalkyl-substituted imidazoles
JPS5769089A (en) * 1980-10-17 1982-04-27 Fuji Photo Film Co Ltd Desensitizer composition
DK162882A (da) * 1981-04-13 1982-10-14 Searle & Co Imidazolderivater eller syreadditionssalte deraf,deres fremstilling og anvendelse
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
DE3369984D1 (en) * 1982-07-12 1987-04-09 Searle & Co 1-(1h-imidazolyl), 1-n-morpholinyl and pyridyl compounds, their preparation and pharmaceutical compositions containing them
DE3238006A1 (de) * 1982-10-13 1984-04-19 Bayer Ag, 5090 Leverkusen Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln
EP0117462A3 (en) * 1983-02-28 1986-08-20 American Cyanamid Company N-(2-4-(1h-imidazol-1-yl)alkyl)arylamides
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
GB8412750D0 (en) * 1984-05-18 1984-06-27 Ici Plc Heterocyclic compounds
US4728663A (en) * 1986-01-13 1988-03-01 American Cyanamid Company N-[(1H-imidazol-1-yl)alkyl]benz[cd]-indol-2-amines and use in inhibiting thromboxane synthetase enzyme
JPH0774205B2 (ja) * 1986-12-04 1995-08-09 三井石油化学工業株式会社 新規イミダゾ−ル誘導体
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
KR920701167A (ko) * 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
EP0485890A3 (en) * 1990-11-16 1992-07-08 Hoechst Aktiengesellschaft Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.

Also Published As

Publication number Publication date
BG98812A (bg) 1995-05-31
NO942374L (no) 1994-06-22
PH30660A (en) 1997-09-16
HUT67372A (en) 1995-03-28
SK75294A3 (en) 1995-04-12
CZ153394A3 (en) 1995-10-18
SI9200411A (en) 1993-09-30
ZA929914B (en) 1993-06-23
IN174436B (es) 1994-12-03
NO942374D0 (es) 1994-06-22
PL172497B1 (pl) 1997-09-30
RU94030470A (ru) 1997-04-27
YU110592A (sh) 1996-01-08
DE69229057D1 (de) 1999-06-02
CN1096781A (zh) 1994-12-28
HRP921457A2 (en) 1996-02-29
JPH07502519A (ja) 1995-03-16
NZ246336A (en) 1995-12-21
US5547972A (en) 1996-08-20
IL104168A (en) 1999-04-11
GB9127304D0 (en) 1992-02-19
RO113985B1 (ro) 1998-12-30
CN1037511C (zh) 1998-02-25
HU9401453D0 (en) 1994-08-29
ATE179416T1 (de) 1999-05-15
WO1993013075A1 (en) 1993-07-08
NO304373B1 (no) 1998-12-07
AU656839B2 (en) 1995-02-16
EP0618907A1 (en) 1994-10-12
HU211598A9 (en) 1995-12-28
DE69229057T2 (de) 1999-10-21
FI943020A0 (fi) 1994-06-22
JP2633087B2 (ja) 1997-07-23
AU3256393A (en) 1993-07-28
RU2118957C1 (ru) 1998-09-20
IL104168A0 (en) 1993-05-13
CA2126177A1 (en) 1993-07-08
EP0618907B1 (en) 1999-04-28
MX9207491A (es) 1993-07-01
FI943020A (fi) 1994-06-22
YU48294B (sh) 1998-05-15

Similar Documents

Publication Publication Date Title
GR3015616T3 (en) Aryl-heteroaryl-carbinol derivatives having an analgesic activity.
ES2131574T3 (es) Derivados de 1-(arilalquil-aminoalquil)imidazol, procedimientos de preparacion y uso como agentes terapeuticos.
GB9121456D0 (en) Triazole antifungal agents
DE3462890D1 (en) Pyridazinones, their preparation and use, medicines containing these pyridazinones
NO167746C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive muramylpeptidderivater.
MY107787A (en) Therapeutic agents
JO1755B1 (en) Therapeutic agents
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
ES8306370A1 (es) "procedimiento para la preparacion de derivados de imidazol".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618907

Country of ref document: ES